Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The following sections cover how The Drip IV Infusion delivers customized B12 cocktails and the essential takeaways for choosing between B12 shots and IV infusions
It is also crucial to consult with healthcare professionals about the medicines and supplements you are taking to avoid potential interactions and ensure a safe and effective protocol
5-Amino-1MQ is an orally bioavailable, cell-permeable small molecule that potently inhibits NNMT (nicotinamide N-methyltransferase), the enzyme responsible for methylating nicotinamide to 1-methylnicotinamide (1-MNA)
Alarelin Dihexa Follistatin 344 GHRP-2 Gonadorelin Hexarelin HGH Fragment 176-191 Liraglutide Mechano Growth Factor N-Acetyl Semax PEG-MGF Pentosan Polysulfate Triptorelin Recently Updated These protocols were most recently reviewed or updated with new data: July 2026: Adamax: Published full nootropic Semax-analog protocol with evidence limits, route context, reconstitution math, and Orbitrex supplies planning June 2026: GHRP-6: Published full GH secretagogue protocol with saturation-dose context, empty-stomach timing, reconstitution math, stack comparisons, and Ion Peptide supplies planning June 2026: VIP: Published full vasoactive intestinal peptide protocol with nasal vs subcutaneous context, lipase monitoring, reconstitution math, and Peptide Partners supplies planning June 2026: FOXO4-DRI: Published full senolytic research protocol with animal-dose context, community-cycle boundaries, reconstitution math, and supplies planning June 2026: Epitalon (Epithalon): Published full AEDG bioregulator protocol with cycle planning, reconstitution math, supplies guidance, and telomere evidence boundaries June 2026: Glutathione: Published full antioxidant protocol with oral, liposomal, intranasal, and IV route context plus supplies planning June 2026: 5-Amino-1MQ: Published full NNMT inhibitor protocol with oral dosing, optional subcutaneous vial math, reconstitution guidance, and supplies planning June 2026: Survodutide: Published full dual GLP-1/glucagon protocol with Phase 2 and Phase 3 trial context, reconstitution math, and supplies planning June 2026: Pinealon: Published full EDR tripeptide protocol with oral/SubQ planning, reconstitution math, and supplies guidance June 2026: Humanin: Published full mitochondrial-derived peptide protocol with HNG evidence boundaries, reconstitution math, and supplies planning June 2026: Thymosin Alpha-1: Published full immune-modulation protocol with twice-weekly dosing, reconstitution, and clinical-trial coverage June 2026: SS-31 (Elamipretide): Published full mitochondria-targeting protocol with dosing, reconstitution, and clinical program review June 2026: KPV: Updated anti-inflammatory mechanism section and community dosing notes June 2026: Retatrutide: Added TRIUMPH Phase 3 interim data references June 2026: BPC-157: Updated regulatory status following FDA Category 2 Category 1 reclassification June 2026: TB-500: Updated regulatory status following FDA reclassification All protocols carry a Last reviewed date
